Abstract
We report the case of a 25-year-old lung and liver transplant recipient who developed respiratory failure. High levels of Epstein-Barr virus (EBV) genome copies were detectable in respiratory tract specimens, while the search for various other viral, bacterial or fungal pathogens remained empty. Post-transplant lymphoproliferative disease was excluded. Due to the rapid progression of respiratory insufficiency, a re-transplantation of the lung was performed. EBV-encoded small RNAs could be demonstrated by in situ hybridization within pneumocytes and lymphocytes of the explanted lung tissue. The clinical situation improved soon after re-transplantation, and the EBV load detected in the lower respiratory tract decreased significantly.
Similar content being viewed by others
References
Kieff E, Rickinson AB (2007) Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology. Lippincott-Williams & Wilkins Publishers, Philadelphia, pp 2603–2654
Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81:4510–4514
Macsween KF, Crawford DH (2003) Epstein-Barr virus-recent advances. Lancet Infect Dis 3:131–140
Golden HD, Chang RS, Prescott W, Simpson E, Cooper TY (1973) Leukocyte-transforming agent: prolonged excretion by patients with mononucleosis and excretion by normal individuals. J Infect Dis 127:471–473
Straus SE, Cohen JI, Tosato G, Meier J (1993) NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 118:45–58
Hsu JL, Glaser SL (2000) Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol 34:27–53
Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757–768
Ternesten-Bratel A, Kjellstrom C, Ricksten A (1998) Specific expression of Epstein-Barr virus in cutaneous squamous cell carcinomas from heart transplant recipients. Transplantation 66:1524–1529
Hyckel P, Schleier P, Meerbach A, Berndt A, Kosmehl H, Wutzler P (2003) The therapy of virus-associated epithelial tumors of the face and the lips in organ transplant recipients. Med Microbiol Immunol 192:171–176
Fan H, Gulley ML (2001) Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn 6:279–289
Baldanti F, Grossi P, Furione M, Simoncini L, Sarasini A, Comoli P, Maccario R, Fiocchi R, Gerna G (2000) High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J Clin Microbiol 38:613–619
Rowe DT, Qu L, Reyes J, Jabbour N, Yunis E, Putnam P, Todo S, Green M (1997) Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 35:1612–1615
Lucas KG, Burton RL, Zimmerman SE, Wang J, Cornetta KG, Robertson KA, Lee CH, Emanuel DJ (1998) Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. Blood 91:3654–3661
Gärtner BC, Schafer H, Marggraff K, Eisele G, Schafer M, Dilloo D, Roemer K, Laws HJ, Sester M, Sester U, Einsele H, Mueller-Lantzsch N (2002) Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease. J Clin Microbiol 40:351–358
Kimura H, Ito Y, Suzuki R, Nishiyama Y (2008) Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease. Rev Med Virol 18:305–319
Krumbholz A, Meerbach A, Zell R, Gruhn B, Henke A, Birch-Hirschfeld E, Wutzler P (2006) Comparison of a LightCycler-based real-time PCR for quantitation of Epstein-Barr viral load in different clinical specimens with semiquantitative PCR. J Med Virol 78:598–607
Costa C, Elia M, Astegiano S, Sidoti F, Terlizzi ME, Solidoro P, Botto S, Libertucci D, Bergallo M, Cavallo R (2008) Quantitative detection of Epstein-Barr virus in bronchoalveolar lavage from transplant and nontransplant patients. Transplantation 86:1389–1394
Stocher M, Leb V, Bozic M, Kessler HH, Halwachs-Baumann G, Landt O, Stekel H, Berg J (2003) Parallel detection of five human herpes virus DNAs by a set of real-time polymerase chain reactions in a single run. J Clin Virol 26:85–93
Lung ML, Lam WK, So SY, Lam WP, Chan KH, Ng MH (1985) Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet 1:889–892
Haller A, von Segesser L, Baumann PC, Krause M (1995) Severe respiratory insufficiency complicating Epstein-Barr virus infection: case report and review. Clin Infect Dis 21:206–209
Gautschi O, Berger C, Gubler J, Laube I (2003) Acute respiratory failure and cerebral hemorrhage due to primary Epstein-Barr virus infection. Respiration 70:419–422
Sriskandan S, Labrecque LG, Schofield J (1996) Diffuse pneumonia associated with infectious mononucleosis: detection of Epstein-Barr virus in lung tissue by in situ hybridization. Clin Infect Dis 22:578–579
Barbera JA, Hayashi S, Hegele RG, Hogg JC (1992) Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 145:940–946
Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, Woodcock AA (1995) Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 50:1234–1239
Remund KF, Best M, Egan JJ (2009) Infections relevant to lung transplantation. Proc Am Thorac Soc 6:94–100
Gottschalk S, Rooney CM, Heslop HE (2005) Post-transplant lymphoproliferative disorders. Annu Rev Med 56:29–44
Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS (1991) Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant 10:877–886; discussion 886–877
Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J (1996) Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naive lung transplant recipient. Am J Respir Crit Care Med 154:1712–1717
Levine SM, Angel L, Anzueto A, Susanto I, Peters JI, Sako EY, Bryan CL (1999) A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipients. Chest 116:1273–1277
Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, McGregor CG, Paya CV (1995) Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 20:1346–1353
Kranz B, Vester U, Becker J, Woltering T, Wingen AM, Paul A, Hoyer PF (2006) Unusual manifestation of posttransplant lymphoproliferative disorder in the esophagus. Transplant Proc 38:693–696
Michelson P, Watkins B, Webber SA, Wadowsky R, Michaels MG (2008) Screening for PTLD in lung and heart-lung transplant recipients by measuring EBV DNA load in bronchoalveolar lavage fluid using real time PCR. Pediatr Transplant 12:464–468
Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO, Taylor DO, Kucheryavaya AY, Hertz MI (2008) Registry of the international society for heart and lung transplantation: twenty-fifth official adult lung and heart/lung transplantation report-2008. J Heart Lung Transplant 27:957–969
Meyers BF, de la Morena M, Sweet SC, Trulock EP, Guthrie TJ, Mendeloff EN, Huddleston C, Cooper JD, Patterson GA (2005) Primary graft dysfunction and other selected complications of lung transplantation: a single-center experience of 983 patients. J Thorac Cardiovasc Surg 129:1421–1429
Hachem RR (2009) Lung allograft rejection: diagnosis and management. Curr Opin Organ Transplant 14:477–482
Grossman EJ, Shilling RA (2009) Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future. Transl Res 153:153–165
Gulley ML (2001) Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 3:1–10
Weigel R, Fischer DK, Heston L, Miller G (1985) Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication. J Virol 53:254–259
Neurohr C, Huppmann P, Leuchte H, Schwaiblmair M, Bittmann I, Jaeger G, Hatz R, Frey L, Uberfuhr P, Reichart B, Behr J (2005) Human herpesvirus 6 in bronchoalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome? Am J Transplant 5:2982–2991
Engelmann I, Welte T, Fuhner T, Simon AR, Mattner F, Hoy L, Schulz TF, Gottlieb J (2009) Detection of Epstein-Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation. J Clin Virol 45:47–53
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krumbholz, A., Sandhaus, T., Göhlert, A. et al. Epstein-Barr virus-associated pneumonia and bronchiolitis obliterans syndrome in a lung transplant recipient. Med Microbiol Immunol 199, 317–322 (2010). https://doi.org/10.1007/s00430-010-0165-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-010-0165-y